Clinical trial
Effects and Safety of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose
NCT02145442 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects and Safety of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose
- Lead sponsor
- Catalysis SL
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- November 30, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.